![](https://www.aiche.org/sites/default/files/styles/ache_portrait_no-up-scale_nocrop/public/images/bio/saul_priceman.jpg?itok=54gQQyTH)
Assistant Professor in the Beckman Research Institute
City of Hope
Dr. Priceman is an Assistant Professor in the Beckman Research Institute of the City of Hope, and is developing Chimeric Antigen Receptor (CAR)-based T cell immunotherapy for solid cancers, with a strong focus on metastatic disease in prostate, breast, and ovarian cancer. His current laboratory research focuses on clinically relevant metastatic cancer models to develop combination therapy strategies to improve the durability and potency of CAR T cells, and ultimately the overall immunotherapy response in solid tumors.